We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates Q&As on Clinical Trials to Evaluate Potential Heart Rhythm Risks
FDA Updates Q&As on Clinical Trials to Evaluate Potential Heart Rhythm Risks
The FDA published a set of revisions to an ICH supplement, answering industry questions on the evaluation of certain drugs’ potential to produce abnormal heart rhythms.
